Science and Development Network
News, views and information about science, technology and the developing world
A rising generics industry in developing nations is helping secure access to cheap drugs for the world's poor. But controversies over patent rules could divert investment from already neglected diseases.
(Photo credit: WHO/TDR/Crump)
Drug-resistant TB needs massive research increase
Multidrug-resistant TB needs more research to equip healthcare workers with the right tools, write Frank G. J. Cobelens and colleagues.
It's a long road to a H5N1 vaccine stockpile
Tadataka Yamada, Alice Dautry and Mark Walport want to see better coordination and financing for a global H5N1 virus vaccine stockpile.
16 April 2008
|
EN
|
中文
Source: New England Journal of Medicine
Change in South Africa medicines approval 'unscientific'
South Africa is set to approve a change to its medicines approval process that opponents fear will circumvent evidence-based evaluation.
28 August 2008
|
EN
Lebanon launches campaign to counter fake drugs
Lebanon has launched an awareness campaign on counterfeit drugs, but commentators say the move doesn't go far enough.
28 August 2008
|
EN